|Articles|March 18, 2022
Supplying CleanCap® Reagent for a COVID-19 Vaccine
Author(s)TriLink BioTechnologies
This case study demonstrates scale-up of mRNA supply chain, increased quality standards, and global supply capabilities within record-breaking time.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
